Insider Trading & Ownership of Frank Clyburn

Location
Conshohocken, PA
Summary
The estimated net worth of Frank Clyburn is at least $15,307,512 dollars as of 20 Apr 2026. Frank Clyburn is the EVP & Pres ? Human Health of Merck & Co., Inc. and owns shares of Merck & Co., Inc. (MRK) stock worth about $11.6M. Frank Clyburn is the Chief Executive Officer of INTERNATIONAL FLAVORS & FRAGRANCES INC and owns shares of INTERNATIONAL FLAVORS & FRAGRANCES INC (IFF) stock worth about $2.7M. Frank Clyburn is the Director of Cencora, Inc. and owns shares of Cencora, Inc. (COR) stock worth about $630.5K. Frank Clyburn is the Director of Revolution Medicines, Inc. and owns shares of Revolution Medicines, Inc. (RVMD) stock worth about $385K.
Signature
/s/ John Mei, Attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Frank Clyburn and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Quick Takeaways

  • Frank Clyburn has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $15,307,512.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Merck & Co., Inc. ($11,596,066).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Frank Clyburn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MRK Merck & Co., Inc. EVP & Pres ? Human Health $11,596,066 30 Oct 2021
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC Chief Executive Officer $2,695,940 01 Mar 2024
COR Cencora, Inc. Director $630,466 05 Mar 2026
RVMD, RVMDW Revolution Medicines, Inc. Director $385,040 26 Jun 2025
KLRA Kailera Therapeutics, Inc. Director 16 Apr 2026

Insider Transactions Reported by Frank Clyburn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .